Inovio Pharmaceuticals Inc. (INO)

Inovio Pharmaceuticals Inc. (INO $2.12)
- $2.12 Cap: $112M
- View INO Profile
- View Questions on INO

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Inovio Pharmaceuticals Inc. (INO $2.12)
- $2.12 Cap: $112M
- View INO Profile
- View Questions on INO

Q: Despite all the short squeezing news on this stock. What do you guys think of INO as a biotech company, balance sheet, insider ownership, pipeline, upcoming earnings, long term outlook, risks, covid pipeline......

Thanks

Read Answer Asked by James on February 02, 2021

Regeneron Pharmaceuticals Inc. (REGN $657.53)
- $657.53 P/E (TTM): 15.47X Cap: $69.10B
- View REGN Profile
- View Questions on REGN
Pfizer Inc. (PFE $24.43)
- $24.43 P/E (TTM): 12.99X Cap: $138.90B
- View PFE Profile
- View Questions on PFE
IMV Inc. (IMV $1.12)
- $1.12 Cap: $13M
- View IMV Profile
- View Questions on IMV
Inovio Pharmaceuticals Inc. (INO $2.12)
- $2.12 Cap: $112M
- View INO Profile
- View Questions on INO
Novavax Inc. (NVAX $7.44)
- $7.44 P/E (TTM): 3.19X Cap: $1.20B
- View NVAX Profile
- View Questions on NVAX
Moderna Inc. (MRNA $24.54)
- $24.54 Cap: $9.58B
- View MRNA Profile
- View Questions on MRNA
BioNTech SE (BNTX $103.14)
- $103.14 Cap: $24.75B
- View BNTX Profile
- View Questions on BNTX

Q: Is there a Canadian company that you would recommend that possibly would benefit from a vaccine to overcome Covid 19, if not what U.S. or international company would you recommend? Thank You.

Read Answer Asked by Brian on July 14, 2020

Amgen Inc. (AMGN $320.20)
- $320.20 P/E (TTM): 24.73X Cap: $172.42B
- View AMGN Profile
- View Questions on AMGN
Johnson & Johnson (JNJ $186.57)
- $186.57 P/E (TTM): 18.05X Cap: $449.32B
- View JNJ Profile
- View Questions on JNJ
Inovio Pharmaceuticals Inc. (INO $2.12)
- $2.12 Cap: $112M
- View INO Profile
- View Questions on INO
Novavax Inc. (NVAX $7.44)
- $7.44 P/E (TTM): 3.19X Cap: $1.20B
- View NVAX Profile
- View Questions on NVAX
Repligen Corporation (RGEN $142.82)
- $142.82 Cap: $8.03B
- View RGEN Profile
- View Questions on RGEN
Moderna Inc. (MRNA $24.54)
- $24.54 Cap: $9.58B
- View MRNA Profile
- View Questions on MRNA
Adaptive Biotechnologies Corporation (ADPT $14.79)
- $14.79 Cap: $2.67B
- View ADPT Profile
- View Questions on ADPT
Sorrento Therapeutics Inc. (SRNE)
- P/E (TTM): -0.1X Cap: $141M
- View SRNE Profile
- View Questions on SRNE

Q: Hello 5i Team,
Could you please tell me the names of the companies that are developing a vaccine against Covid 19. Is there an ETF that tracks them?
Thanks,
Antoine

Read Answer Asked by Antoine on June 30, 2020